Does REMDESIVIR Cause Infusion site extravasation? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Infusion site extravasation have been filed in association with REMDESIVIR (Veklury). This represents 1.4% of all adverse event reports for REMDESIVIR.
144
Reports of Infusion site extravasation with REMDESIVIR
1.4%
of all REMDESIVIR reports
2
Deaths
2
Hospitalizations
How Dangerous Is Infusion site extravasation From REMDESIVIR?
Of the 144 reports, 2 (1.4%) resulted in death, 2 (1.4%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
ECULIZUMAB (59)
Which REMDESIVIR Alternatives Have Lower Infusion site extravasation Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN